Degen D - Search Results

1

In vitro activity of the benzotriazine dioxide SR 4233 against human tumour colony-forming units.

Hanauske AR, Ross M, Degen D, Hilsenbeck SG, Von Hoff DD. Hanauske AR, et al. Among authors: degen d. Eur J Cancer. 1993;29A(3):423-5. doi: 10.1016/0959-8049(93)90400-a. Eur J Cancer. 1993. PMID: 8398345

2

Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells.

Hanauske AR, Degen D, Hilsenbeck SG, Bissery MC, Von Hoff DD. Hanauske AR, et al. Among authors: degen d. Anticancer Drugs. 1992 Apr;3(2):121-4. doi: 10.1097/00001813-199204000-00008. Anticancer Drugs. 1992. PMID: 1356030

3

Lack of effects of recombinant human interleukin-4 on in vitro colony formation of freshly explanted human tumor cells.

Hanauske AR, Degen D, Marshall MH, Trotta PP, Von Hoff DD. Hanauske AR, et al. Among authors: degen d. Invest New Drugs. 1992 Nov;10(4):269-73. doi: 10.1007/BF00944180. Invest New Drugs. 1992. PMID: 1487400

4

Effects of recombinant human interleukin-1 alpha on clonogenic growth of primary human tumors in vitro.

Hanauske AR, Degen D, Marshall MH, Hilsenbeck SG, Banks P, Stuckey J, Leahy M, Von Hoff DD. Hanauske AR, et al. Among authors: degen d. J Immunother (1991). 1992 Apr;11(3):155-8. doi: 10.1097/00002371-199204000-00001. J Immunother (1991). 1992. PMID: 1515420

5

Activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human tumor colony forming units.

Hanauske AR, Degen D, Marshall MH, Hilsenbeck SG, Grindey GB, Von Hoff DD. Hanauske AR, et al. Among authors: degen d. Anticancer Drugs. 1992 Apr;3(2):143-6. doi: 10.1097/00001813-199204000-00012. Anticancer Drugs. 1992. PMID: 1525392

6

Preclinical activity of ilmofosine against human tumor colony forming units in vitro.

Hanauske AR, Degen D, Marshall MH, Hilsenbeck SG, McPhillips JJ, Von Hoff DD. Hanauske AR, et al. Among authors: degen d. Anticancer Drugs. 1992 Feb;3(1):43-6. doi: 10.1097/00001813-199202000-00008. Anticancer Drugs. 1992. PMID: 1623215

7

Activity of DMP 840, a new bis-naphthalimide, on primary human tumor colony-forming units.

Cobb PW, Degen DR, Clark GM, Chen SF, Kuhn JG, Gross JL, Kirshenbaum MR, Sun JH, Burris HA 3rd, Von Hoff DD. Cobb PW, et al. Among authors: degen dr. J Natl Cancer Inst. 1994 Oct 5;86(19):1462-5. doi: 10.1093/jnci/86.19.1462. J Natl Cancer Inst. 1994. PMID: 8089865

8

In vitro cytotoxicity of hepsulfam against human tumor cell lines and primary human tumor colony forming units.

Marshall MV, Marshall MH, Degen DR, Roodman GD, Kuhn JG, Ross ME, Von Hoff DD. Marshall MV, et al. Among authors: degen dr. Stem Cells. 1993 Jan;11(1):62-9. doi: 10.1002/stem.5530110111. Stem Cells. 1993. PMID: 8457783

9

Activity of CPT-11 (irinotecan hydrochloride), a topoisomerase I inhibitor, against human tumor colony-forming units.

Shimada Y, Rothenberg M, Hilsenbeck SG, Burris HA 3rd, Degen D, Von Hoff DD. Shimada Y, et al. Among authors: degen d. Anticancer Drugs. 1994 Apr;5(2):202-6. doi: 10.1097/00001813-199404000-00011. Anticancer Drugs. 1994. PMID: 8049503

10

Effects of the hematopoietic growth factors GM-CSF, IL-3, and IL-6 on human tumor colony-forming units taken directly from patients.

Izquierdo MA, Degen D, Myers L, Levitt DJ, Von Hoff DD. Izquierdo MA, et al. Among authors: degen d. Ann Oncol. 1995 Nov;6(9):927-32. doi: 10.1093/oxfordjournals.annonc.a059361. Ann Oncol. 1995. PMID: 8624297 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters